SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-135407
Filing Date
2021-04-28
Accepted
2021-04-28 07:31:52
Documents
7
Period of Report
2021-06-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A d852791ddef14a.htm DEF 14A 331700
2 GRAPHIC g8527912.jpg GRAPHIC 139496
3 GRAPHIC g852791g11p21.jpg GRAPHIC 23775
4 GRAPHIC g852791g31o79.jpg GRAPHIC 28076
5 GRAPHIC g852791g81l50.jpg GRAPHIC 26183
6 GRAPHIC g852791g90r10.jpg GRAPHIC 38062
7 GRAPHIC g852791hn.jpg GRAPHIC 96410
  Complete submission text file 0001193125-21-135407.txt   811495
Mailing Address 2 WEST LIBERTY BLVD #100 MALVERN PA 19355
Business Address 2 WEST LIBERTY BLVD #100 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Filer) CIK: 0001563577 (see all company filings)

IRS No.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39114 | Film No.: 21861353
SIC: 2834 Pharmaceutical Preparations